SAN DIEGO, May 05, 2017 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (NASDAQ:CYTX) (the “Company”), announced today that the Compensation Committee of the Company's Board of Directors granted non-qualified stock
Cytori Therapeutics Inc
04/11 Cytori Therapeutics' stock plunges 35% premarket after stock offering prices .. 04/11 Cytori Therapeutics' stock
Presentation on March 10, 2015, at 11:00 AM, Pacific Time Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that Dr. Marc H ... Register now to create your own custom streaming stock watchlist. NYSE, AMEX, and ASX quotes …
Cytori Therapeutics Inc (CYTX). * Cytori announces pricing of $9.5m public offering of common stock. * Says public offering of 8.60 million common shares priced at $1.10per share Source text for Eikon: Further company coverage: Cytori …
I would like to believe stem cell therapies – and CYTX’s technology, specifically – is a game ... This appears to conflict with SEC’s Regulation Fair Disclosure. Stock approaching bubble territory? The company announced clearance of a …
Cytori Therapeutics Inc (NASDAQ:CYTX) shares are down big today, falling below the 52-week low of $0.23 cent, actually reaching $0.16 at one point in the day. The stock is being sold off after the company released a bit of news. Cytori …
Stock analysis based on fundamentals means looking at financial statements in addition to the Cytori Therapeutics stock price ... Like any other income statement, the CYTX income statement also itemizes revenue, operating …
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, …
Cytori Therapeutics Inc (CYTX) was among the biggest gainers on the Russell 2000 for Tuesday May 17 as the stock popped 35.92% to $3.33, representing a gain of $0.88 per share. Some 1.09 million shares traded hands on 3,274 …